Celecoxib
- Product NDC
- 68788-8936
- 11-digit product format
- 687888936
- Labeler code
- 68788
- Product ID
- 68788-8936_ae849a94-47c3-46c6-ab75-c025a5dba2ec
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Celecoxib
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Preferred Pharmaceuticals Inc.
- Application
- ANDA200562
- Marketing category
- ANDA
- Marketing start
- 2015-10-15
- Marketing end
- 0000-00-00
- Substance
- CELECOXIB
- Active strength
- 200 mg/1
- Pharmacologic classes
- Cyclooxygenase Inhibitors [MoA],Anti-Inflammatory Agents, Non-Steroidal [CS],Nonsteroidal Anti-inflammatory Drug [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68788-8936-3 | 2020-11-09 | C162847 | 48780-1 | 9d75b9d1-01a7-f424-e053-dadaa90a57ce | 2c514be2-3259-481a-bb5d-6f872c64b43e |
| 68788-8936-6 | 2020-11-09 | C162847 | 48780-1 | 9d75b9d1-01a7-f424-e053-dadaa90a57ce | 2c514be2-3259-481a-bb5d-6f872c64b43e |
| 68788-8936-9 | 2020-11-09 | C162847 | 48780-1 | 9d75b9d1-01a7-f424-e053-dadaa90a57ce | 2c514be2-3259-481a-bb5d-6f872c64b43e |
| 68788-8936-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-01a7-f424-e053-dadaa90a57ce | 2c514be2-3259-481a-bb5d-6f872c64b43e |
| 68788-8936-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-01a7-f424-e053-dadaa90a57ce | 2c514be2-3259-481a-bb5d-6f872c64b43e |
| 68788-8936-9 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d1-01a7-f424-e053-dadaa90a57ce | 2c514be2-3259-481a-bb5d-6f872c64b43e |